1. Introduction {#sec1}
===============

Many metabolic processes are synchronized to day-night cycles by the circadian clock, thereby anticipating changes in metabolic activity associated with feeding or fasting and physical activity or rest [@bib1]. In our modern "24/7" society, however, many individuals do not adhere to the lifestyle imposed upon us by nature. In this respect, epidemiological studies have shown that circadian misalignment -- desynchronization between the intrinsic circadian and behavioral cycles, as is typical in shift-work -- is associated with obesity, insulin resistance and type 2 diabetes mellitus (T2DM) [@bib2], [@bib3], [@bib4], [@bib5]. Moreover, intervention studies have shown that challenging behavior by controlled circadian misalignment results in metabolic aberrations like decreased glucose tolerance and insulin sensitivity [@bib6], [@bib7], [@bib8].

Circadian rhythms are governed by a central circadian clock, which is situated in the suprachiasmatic nucleus of the hypothalamus and is sensitive to light as the most important time cue (*Zeitgeber*) [@bib9]. Interestingly, peripheral tissues have their own clocks. These peripheral clocks are synchronized by the central clock, but they can also be influenced by behavior, such as feeding or exercise [@bib10], [@bib11]. The peripheral clock consists of transcriptional-translational feedback loops. The positive loop consists of the heterodimer of the CLOCK (circadian locomotor output cycles kaput) and BMAL1 (brain and muscle ARNT-like 1) proteins. The negative feedback loop is mediated via heterodimers of the proteins PER (Period) and CRY (Cryptochrome), which repress CLOCK/BMAL1-controlled gene expression [@bib9], [@bib12]. Interestingly, in mouse and cell models, several components of the molecular clock have been causally linked to mitochondrial metabolism [@bib13], mitochondrial integrity and density [@bib14], mitochondrial dynamics [@bib15] and metabolic flexibility [@bib16]. So far however, it is unknown whether mitochondrial metabolism also displays a day-night rhythm in human skeletal muscle. Such data would be relevant, since reduced skeletal muscle oxidative capacity is associated with T2DM [@bib17], [@bib18]. It is tempting to speculate that disturbances in the day-night rhythm may affect muscle mitochondrial metabolism and thereby deteriorate metabolic health.

Here, we investigated whether skeletal muscle mitochondrial function displays day-night rhythmicity by taking multiple muscle biopsies from healthy, lean volunteers within a 24 h period, under tightly controlled experimental conditions. We used a research setting that reflects real life conditions, with regular meals, physical activity and a regular sleep/wake cycle. For this reason we use the term "day-night rhythm" instead of "circadian rhythm" [@bib19]. We here show that gene expression in muscle displays rhythmicity, which is specifically evident for the core components of the molecular clock. Furthermore, we are the first to show the presence of a day-night rhythm in human skeletal muscle oxidative capacity.

2. Material and methods {#sec2}
=======================

2.1. Participants {#sec2.1}
-----------------

Twelve young lean male Caucasian individuals (age ± SD: 22.2 ± 2.3 years, BMI ± SD: 22.4 ± 2.0 kg/m^2^) participated in this study. The participants did not engage in exercise more than 3 h per week, were non-smokers, had no active diseases and used no medication, verified by a medical questionnaire. Participants were selected for having a regular sleep duration (normally 7--9 h/night), not having done shift work or having traveled across more than one time zone for at least 3 months. A morningness-eveningness questionnaire (MEQ-SA) was used to exclude extreme morning larks or night owls (MEQ-SA score mean ± SD: 50 ± 7). All participants provided written informed consent. The study was approved by the Ethics Committee of the Maastricht University Medical Center, monitored by the Clinical Trial Center Maastricht and conducted in accordance with the principles of the declaration of Helsinki. All measurements were performed between November 2014 and July 2015. The study was registered at [clinicaltrials.gov](http://clinicaltrials.gov){#intref0010} with identifier [NCT02261168](ctgov:NCT02261168){#intref0015}.

2.2. Pre-study conditions {#sec2.2}
-------------------------

One week prior to the study, participants were instructed to maintain a standardized lifestyle. This lifestyle included (trying to) sleep every night from 11 PM until 7 AM, eating breakfast, lunch and dinner at regular times (at 9 AM, 2 PM and 7 PM) with no in-between snacks or drinks other than water. In this period subjects refrained from alcohol and caffeine. Participants were instructed not to engage in exercise three days prior to the study. Two days before the study, we provided standardized meals (see below) to ensure standardized caloric and macronutrient intake for all participants. Lifestyle was monitored by accelerometry (activPAL3 physical activity monitor, PAL Technologies, Glasgow, UK) together with food- and sleep-diaries, which were checked at the start of the first study-day.

2.3. Study design {#sec2.3}
-----------------

Participants were admitted to the research unit at noon on study day 1 and stayed for 44 h in total, under standardized conditions mimicking a real-life situation. The first study-day was mainly used to standardize and monitor meals, physical activity and bedtime. Meals were provided at fixed times (9 AM, 2 PM and 7 PM). To prevent a sedentary lifestyle, participants went for a 15-minute low-intensity walk accompanied by a researcher, one hour after every meal. Directly hereafter, participants were instructed to stand for 15 minutes before they were allowed to sit again. In-between meals, physical activity and tests, the participants stayed in a respiration chamber; a small room with a bed, toilet, sink, desk, chair, TV and computer. During the first study-day we performed no measurements. At 11 PM, the lights of the respiration chamber were turned off and the participants were instructed to try to sleep. During this night, sleeping metabolic rate was measured by whole-room indirect calorimetry (Omnical, Maastricht Instruments, Maastricht, The Netherlands) [@bib20].

The second study-day, participants were awakened at 6:30 AM. Hereafter, participants swallowed a telemetric pill for measurement of core-body temperature. Next, an intravenous cannula was placed in the forearm for subsequent blood-draws. The first blood-draw was at 8 AM, followed by an indirect calorimetry measurement using a ventilated hood while awake and at rest in supine posture to calculate resting energy expenditure and substrate oxidation. Directly hereafter, the first skeletal muscle biopsy was taken (described below). These measurements (blood draw, ventilated hood measurement and skeletal muscle biopsy) were repeated five times within 24 h: at 8 AM, 1 PM, 6 PM, 11 PM and 4 AM the next day. Additional blood samples were taken 2-hourly (10 AM, 12 PM, 2 PM, 4 PM, 8 PM, 10 PM, 0 AM, 2 AM, 6 AM and 8 AM). The timing of meals and physical activity was similar to study-day 1 and subjects stayed within the respiration chamber in-between measurements. After the 11 PM biopsy, participants went back to the respiration chamber to sleep with lights off. At 4 AM, the participant was awakened and the last measurements were performed, after which the subject was allowed to sleep until 7 AM. After the 8 AM blood draw the study protocol ended.

2.4. Study meals {#sec2.4}
----------------

Two days before the study and during the study participants were provided with standardized meals, according to Dutch and US dietary guidelines. Caloric intake for consumption at home was calculated by multiplying the estimated resting metabolic rate, obtained with the Harris-Benedict formula [@bib21] with an activity factor of 1.5. Participants were provided with optional extra snacks to eat with their meals if they were still hungry, up to an activity factor of 1.7. For the first study-day in the laboratory, energy requirement was calculated by multiplying the estimated resting metabolic rate with an activity factor of 1.35, because of limited physical activity in the research facility. For the second study-day, energy requirement was calculated by multiplying the sleeping metabolic rate of the first study night (measured by whole-room indirect-calorimetry) by 1.5.

During the study days, participants received 3 meals daily. Breakfast accounted for ∼21 energy%, lunch for ∼30 energy% and dinner for ∼49 energy%. Daily macronutrient composition was ∼52 energy% as carbohydrates, ∼31 energy% as fat (∼9% saturated) and ∼14 energy% as protein. No snacks or drinks other than water were provided in-between meals.

2.5. Skeletal muscle biopsies and respirometry {#sec2.5}
----------------------------------------------

Five skeletal muscle biopsies were obtained from the m. vastus lateralis according to the Bergström method [@bib22] under local anesthesia (1% lidocaine, without epinephrine). Each biopsy was taken from a separate incision at least 2 cm from the previous incision, moving from distal to proximal. The first biopsy was randomly taken from the left or right leg, and each subsequent biopsy was taken from the other leg. Part of the biopsy was immediately placed in ice-cold preservation medium (BIOPS, OROBOROS Instruments, Innsbruck, Austria) and used for measurement of mitochondrial oxidative capacity. For this analysis, intact muscle fibers were permeabilized and measured for oxygen consumption upon several substrates using an Oxygraph (OROBOROS Instruments). During the assay, muscle fibers were supplemented with malate, octanoylcarnitine, ADP, glutamate, succinate and carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) as described previously [@bib23]. The remaining part of the muscle biopsy was immediately frozen in melting isopentane and stored in −80 °C until further analysis.

2.6. Indirect calorimetry {#sec2.6}
-------------------------

To calculate whole-body energy expenditure, respiratory exchange ratio (RER), glucose- and fat-oxidation, oxygen consumption and carbon dioxide production were measured with an automated respiratory gas analyzer using a ventilated hood system (Omnical; IDEE, Maastricht, the Netherlands). Calculations of energy expenditure and substrate oxidation were made with the assumption of a negligible protein oxidation [@bib24], [@bib25].

2.7. Measurement of core-body temperature {#sec2.7}
-----------------------------------------

Core-body temperature was measured by a swallowed telemetric pill (CorTemp HT150002; HQ Inc., Palmetto, FL, USA). The telemetric pill measured the core-body temperature every 10 s and sent the information wirelessly to a portable receiver worn outside the body on the stomach. For further analysis, we used temperature averages of every 10 min, after excluding false measurements.

2.8. Gene transcript quantification {#sec2.8}
-----------------------------------

RNA was isolated from 50 mg of muscle material by TRIzol lysis (Qiagen, Hilden, Germany). RNA was further purified by the RNeasy kit from Qiagen (Hilden, Germany).

Microarray analysis: RNA integrity was assessed using a Bioanalyzer 2100 (Agilent) and RIN were above 9.0. RNAs were then processed to generate labeled ssDNA using the Whole Transcript cDNA synthesis and amplification and the Terminal Labeling kit as suggested by the manufacturer (Affymetrix). Samples were hybridized to HuGene 2.0 arrays and native CEL files imported into GeneSpring (v13.1.1, Agilent) after quality controls using the Affymetrix Expression Console. The RMA16 algorithm was used for summarization and data was normalized to the median of all samples. Normalized intensity values were used to generate a self-organized map (distance metric: Euclidean; number of iterations: 500). Protein-encoding genes from specific clusters were searched against the GO Biological Process, KEGG and Reactome databases using the Metascape tool [@bib26]. Microarray data have been deposited in NCBIs Gene Expression Omnibus (GEO, <http://www.ncbi.nlm.nih.gov/geo/>) and are accessible through GEO accession number [GSE79934](ncbi-geo:GSE79934){#intref0025}.

RT-QPCR: RNA integrity was assessed using a Bioanalyzer (Agilent Technologies, Santa Clara, USA) and yield was measured using a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, USA). The high-capacity RNA-to-cDNA kit from Applied Biosystems (Foster City, USA) was used for transcribing 0.5 μg RNA to cDNA. Transcript abundance was determined using a 7900HT Fast Real-Time PCR System (Applied Biosystems, Waltham, USA). To minimize the variability in reference gene normalization, the geometric mean of three reference genes (*RPL26*, *GUSB* and *CYPB*), which were individually stably expressed in time, was used. This geometric mean was used as the internal reference for comparative gene expression analysis in the remainder of the study [@bib27].

2.9. Protein analysis {#sec2.9}
---------------------

Western blot analyses were performed in RIPA-lysates of human muscle tissue. Protein concentration was determined using the Bio-Rad RC/DC kit (Bio-Rad Laboratories, Veenendaal, The Netherlands). Equal amounts of protein were loaded on 12% TGX gels (Bio-Rad Laboratories) or 4--12% Bolt gradient gels (Novex, Thermo Fisher Scientific, Bleiswijk, The Netherlands). Proteins were transferred to nitrocellulose with the Trans-Blot Turbo transfer system (Bio-Rad Laboratories). Primary antibodies: a cocktail of mouse monoclonal antibodies directed against human OXPHOS (dilution 1:10,000; ab110411, Abcam, Cambridge, UK), two mitochondrial markers directed against TOMM20 (dilution 1:10,000; ab186734; Abcam), porin/VDAC (dilution 1:10,000; sc-8828, Santa Cruz Biotechnology, Dallas, Texas), SR-actin (dilution 1:5,000; A-2172; Sigma Aldrich, Zwijndrecht, The Netherlands), PGC-1 (dilution 1:10,000, 516,557, Calbiochem), FIS-1 (dilution 1:1000, sc-98900, Santa Cruz Biotechnology, Dallas, Texas), PINK-1 (dilution 1:2000, sc-33796, Santa Cruz Biotechnology, Dallas, Texas) and OPA-1 (dilution 1:2500, 612,606, Becton Dickinson). The specific proteins were detected using secondary antibodies conjugated with IRDye680 or IRDye800, and were quantified with the CLx Odyssey Near Infrared Imager (Li-COR, Westburg, Leusden, The Netherlands).

2.10. Statistics {#sec2.10}
----------------

Data are presented as mean ± SEM (standard error of the mean) unless indicated otherwise. Statistical analyses were performed with the use of IBM Statistical Package for Social Sciences for MAC, version 23 (SPSS, Inc.). The effect of time on outcome variables was analyzed by repeated measures ANOVA. If the assumption of sphericity was violated (Mauchly\'s test), we applied Greenhouse-Geisser\'s correction. In case repeated measures ANOVA revealed significant effects for the oxidative capacity and indirect calorimetry analyses, Bonferroni adjusted post-hoc analyses were applied to look at significant differences between specific time-points. Statistical significance was defined as a p-value \< 0.05. In addition, if repeated measures ANOVA resulted in a significant effect of time for targets of mRNA and protein expression and oxidative capacity states, we tested for rhythmicity using the JTK_CYCLE package in R 3.2.1 with Windows 8 [@bib28]. For this analysis, values were normalized to subject mean prior to analysis.

3. Results and discussion {#sec3}
=========================

3.1. Participants adhered to a controlled normal lifestyle and displayed a normal day-night rhythm in core-body temperature {#sec3.1}
---------------------------------------------------------------------------------------------------------------------------

To investigate whether mitochondrial oxidative capacity displays a day-night rhythm, we performed an observational study in which twelve young lean male volunteers were admitted to our metabolic research unit for two days under controlled conditions, mimicking our normal daily life. The study protocol is graphically depicted in [Figure 1](#fig1){ref-type="fig"}. Prior to the study days, subjects were instructed to adhere to a standardized lifestyle, including fixed sleeping times, which was monitored by accelerometry. During the second study-day we recorded core-body temperature to examine the presence of a normal day-night rhythm ([Supplemental Fig. 1](#appsec2){ref-type="sec"}). Indeed, all subjects showed a characteristic day--night pattern in core-body temperature with highest temperature at the end of the day and a decrease in temperature after midnight [@bib29], indicating that chronotypes were similar across participants.

3.2. Human skeletal muscle displays oscillations in RNA of metabolic and core molecular clock genes {#sec3.2}
---------------------------------------------------------------------------------------------------

During the second study day, we performed five consecutive skeletal muscle biopsies. To prevent meal interference, the biopsies were taken immediately before the three meals (8 AM, 1 PM, 6 PM), before bedtime (11 PM) and one time during the night (4 AM) after waking up the participant.

To examine if skeletal muscle displays rhythmicity in gene expression, we analyzed RNA using DNA microarrays in subsequent biopsies from a single donor with a representative rhythm in mitochondrial oxidative capacity. This analysis revealed that 14.5% of transcripts (4094 out of 28,168) displayed a cyclic expression peaking at different times, 75% of them corresponding to protein-encoding transcripts ([Figure 2](#fig2){ref-type="fig"}A). Term enrichment against Gene Ontology, KEGG and Reactome databases indicated that gene clusters displaying a maximal expression in the late evening or during the night (11 PM, 4 AM) are notably related to the core clock machinery (4 AM, [Figure 2](#fig2){ref-type="fig"}B) including *REV-ERB-α*, *REV-ERB-β*, *PER3* and *DBP* and to the tricarboxylic acid (TCA) cycle/respiratory electron transport chain (11 PM, [Figure 2](#fig2){ref-type="fig"}C) such as components of NADH dehydrogenase complexes (*NDUFA4*, *NDUFA8*) and of ATP synthase (*ATP5F1*, *ATP5G3*, *APTP5A1*, *ATP5L*). Collectively, these analyses suggested the existence of a functional core clock machinery and oscillations in mitochondrial metabolism in human skeletal muscle.

Expression of core clock genes was validated in all participants by RT-QPCR assays. *TTN* mRNA expression, measured as an arrhythmic muscle filament gene, did not vary throughout the 24-hour period (p = 0.331, [Figure 3](#fig3){ref-type="fig"}A). *CLOCK* mRNA showed significant variation over time (ANOVA p \< 0.001), but rhythmicity was of rather low amplitude (JTK_CYCLE p \< 0.001; [Figure 3](#fig3){ref-type="fig"}B), consistent with previous observations in several mouse tissues [@bib30]. *BMAL1* mRNA exhibited a robust sinusoidal rhythm, with highest expression around midnight, and lowest expression in the morning and early afternoon (ANOVA p \< 0.001, JTK_CYCLE p \< 0.001; [Figure 3](#fig3){ref-type="fig"}B). Of the negative feedback loop, *PER2* was most abundantly expressed in the early morning (p = 0.019, [Figure 3](#fig3){ref-type="fig"}C). *CRY1* was most highly expressed in the night, however the amplitude was rather low (p = 0.006, [Figure 3](#fig3){ref-type="fig"}C). Both were confirmed to be rhythmic by JTK_CYCLE (p \< 0.001).

Together, our data show robust rhythmicity of the molecular clock in human skeletal muscle, which is consistent with the demonstration of an oscillating molecular clock in other human cells and tissues like leukocytes [@bib31], follicle cells [@bib32] and adipose tissue [@bib33] and in primary cultures of human muscle [@bib34]. In addition, micro-array analysis in sequential biopsies obtained from a single donor revealed cyclic expression of several clusters of genes, including genes involved in important mitochondrial pathways. A previous study investigating the molecular clock in human adipose tissue biopsies demonstrated peak-expression of BMAL1 at the very end of the light-phase, similar to our current results in human skeletal muscle [@bib33]. Interestingly, that study examined adipose tissue gene expression under a standardized circadian rhythm protocol with subjects in the resting condition and with hourly nutritional drinks, thereby limiting the influence of behavior on the core molecular clock expression. The similarity in results suggests that the molecular clock patterns we observe in skeletal muscle may indeed be dominated by circadian rhythmicity. This is further underscored by findings in animals, as in mouse skeletal muscle [@bib35] and mouse liver [@bib13], [@bib15], BMAL1 mRNA is highest at the end of the dark-phase and beginning of the light phase. Since mice are nocturnal animals, this corresponds with a highest BMAL1 expression at the end of the active phase and beginning of the rest phase, similar to our findings in human skeletal muscle.

3.3. Human skeletal muscle oxidative capacity displays a day-night rhythm {#sec3.3}
-------------------------------------------------------------------------

To investigate whether the rhythmicity in mitochondrial and molecular clock genes was also reflected in a day-night rhythm of muscle mitochondrial oxidative capacity, we performed high-resolution respirometry in freshly isolated permeabilized muscle fibers. Skeletal muscle oxidative capacity demonstrated a clear day-night rhythm, with a significant time effect in ADP-stimulated (state 3) respiration fueled by different substrates (state 3 MO, state 3 MOG and state 3 MOGS p = 0.042; 0.016; 0.042 respectively, [Figure 4](#fig4){ref-type="fig"}A). Mitochondrial state 3 respiration was lowest at 1 PM, and highest at 11 PM (state 3 MOGS: 80.6 ± 14.0 vs. 95.8 ± 16.3 pmol/mg/sec, mean ± SD). Differences between these time-points were statistically significant for state 3 MO (p = 0.032) and state 3 MOG (p = 0.027), although it just did not reach significance for state 3 MOGS (p = 0.132) after Bonferroni adjustment for multiple testing. Furthermore, JTK_CYCLE analysis of mitochondrial respiration confirmed rhythmicity for state 3 MO (p = 0.007), 3 MOG (p = 0.039) and 3 MOGS (0.041). Maximally uncoupled respiration, reflecting the maximal capacity of the electron transport system, demonstrated similar oscillations although the effect of time did not reach significance (p = 0.121, [Figure 4](#fig4){ref-type="fig"}B). It is interesting to note that the difference in mitochondrial state 3 respiration between 1 PM and 11 PM was on average 20%, which is in the same range as the difference in mitochondrial function between patients with T2DM and BMI-matched controls [@bib17], [@bib36], indicating that the magnitude of the day-night rhythm in mitochondrial function is of physiological relevance. Previous studies in animal models of metabolic diseases do show disrupted circadian rhythmicity in the molecular clock of metabolic tissues and in plasma metabolites [@bib37], [@bib38], and it is therefore tempting to speculate that day-night rhythmicity in muscle mitochondrial metabolism is altered in T2DM and pre-diabetic patients. Such disturbances in circadian rhythmicity of mitochondrial function may contribute to reduced metabolic flexibility that is observed in metabolically compromised individuals and thereby contribute to the development of metabolic diseases, consistent with findings that circadian misalignment is associated with obesity and T2DM [@bib2], [@bib3], [@bib4]. If this is indeed the case, restoring circadian rhythmicity may comprise a potential new basis for lifestyle advice and provide treatment options for T2DM.

How mitochondrial function can show circadian rhythmicity can not be completely revealed by the current study in humans. However, to investigate if the rhythm in mitochondrial respiration is caused by intrinsic variation in mitochondrial oxidative capacity, rather than by variation in mitochondrial density, we measured several markers of mitochondrial content. Mitochondrial-DNA copy number -- the ratio between the DNA copy number of a mitochondrial (ND1) and a nuclear gene (LPL) -- did not reveal a day-night rhythm (p = 0.437, [Figure 5](#fig5){ref-type="fig"}A). Also, western blot analysis of structural subunits of the five mitochondrial respiratory chain complexes did not reveal a statistically significant effect of time ([Figure 5](#fig5){ref-type="fig"}B--G). In addition, the mitochondrial outer membrane proteins VDAC and TOMM-20 did not display day-night rhythmicity ([Figure 5](#fig5){ref-type="fig"}H--I). The non-mitochondrial protein SR-Actin was also stable throughout the day ([Figure 5](#fig5){ref-type="fig"}J). Together, these results suggest that in skeletal muscle, intrinsic mitochondrial function (rather than mitochondrial content) displays circadian rhythmicity.

We next investigated whether mitochondrial dynamics or mitochondrial biogenesis could play a role in the circadian rhythmicity of intrinsic mitochondrial function. Mitochondrial fission and fusion occur as a result of changes in energy demand, influence substrate metabolism and are controlled by the circadian clock in mouse liver [@bib15], [@bib39]. Here, we quantified proteins involved in mitochondrial biogenesis and mitochondrial dynamics in skeletal muscle biopsies. PGC-1α, the master regulator of mitochondrial biogenesis, did not show a significant difference over time (p = 0.901, [Figure 6](#fig6){ref-type="fig"}A). Interestingly however, FIS1, a marker of mitochondrial fission, displayed significant time-differences, with a pattern matching the rhythm in mitochondrial oxidative capacity (p = 0.016, [Figure 6](#fig6){ref-type="fig"}B), although JTK_CYCLE analysis did not confirm significant rhythmicity. PINK-1, a marker of mitophagy, displayed a rhythm opposing FIS-1, although this time-effect just did not reach statistical significance (p = 0.061, [Figure 6](#fig6){ref-type="fig"}C). Noteworthy, in murine liver FIS-1 and PINK-1 24 h expression patterns are also opposed [@bib15]. Furthermore, the mitochondrial fusion marker OPA-1 showed a significant decrease over time, across all time points (p = 0.045, [Figure 6](#fig6){ref-type="fig"}D, without significant rhythmicity in JTK_CYCLE analysis). These results suggest that mitochondrial dynamics may be involved in governing mitochondrial capacity around the clock, although mechanistic studies in preclinical models are needed to further investigate underlying mechanisms.

The physiological relevance of the rhythmicity in oxidative capacity cannot be deduced from the current study. It is, however, interesting to note that aerobic performance also peaks later in the day [@bib40], [@bib41]. Our results could therefore form a physiological explanation for these findings. An earlier study found that chronotype influences the time-point of peak performance [@bib41]. In our study, we only included participants with an average chronotype. Future studies will be needed to investigate whether early and late chronotypes have a different time-point of peak mitochondrial function.

3.4. Whole-body energy expenditure peaks before midnight {#sec3.4}
--------------------------------------------------------

We next examined whether day-night rhythmicity in muscle mitochondrial function was also associated with rhythmicity in whole-body measures of energy metabolism. To this end, we performed indirect calorimetry analyses to determine resting energy expenditure and substrate oxidation at the same time points of the muscle biopsies. Interestingly, similar to mitochondrial respiratory capacity, resting energy expenditure showed a significant time effect, with highest energy expenditure at 11 PM (p \< 0.001 for the time-effect; p = 0.005 for Bonferroni adjusted post-hoc analysis 11 PM vs 4 AM; [Figure 7](#fig7){ref-type="fig"}A). It is well known that lowest levels of energy expenditure can be measured when subjects are asleep, denoted as sleeping metabolic rate. Even though the participants were awakened before measurements, resting energy expenditure was still lowest at 4 AM. This clearly illustrates day-night rhythmicity in energy expenditure, independent of sleep. RER, carbohydrate oxidation and fat oxidation displayed variation with feeding and fasting periods, with a significantly lower carbohydrate oxidation and RER, and a higher fat oxidation in the fasted state (8 AM and 4 AM) and a higher carbohydrate oxidation and RER, and a lower fat oxidation in the fed state (1 PM, 6 PM and 11 PM) (p \< 0.001 for the time-effect in RER and carbohydrate oxidation and p = 0.007 for the time-effect in fat oxidation, [Figure 7](#fig7){ref-type="fig"}B--D). Bonferroni-adjusted post-hoc analyses confirmed that RER, carbohydrate- and fat-oxidation were significantly different at 6 PM and 11 PM, when compared with 8 AM and 4 AM (p \< 0.05; [Figure 7](#fig7){ref-type="fig"}A--D).

3.5. Plasma metabolites peak according to meals {#sec3.5}
-----------------------------------------------

To examine the diurnal pattern in circulating substrates, we took 15 blood samples throughout the second study-day to assess glucose, insulin, free fatty acids and triglycerides ([Figure 8](#fig8){ref-type="fig"}A--D). As expected, plasma glucose and insulin displayed marked peaks after the meals, with an overall maximum after the dinner, being the most energy-dense meal. Furthermore, plasma glucose increased slightly during the late evening and night, possibly reflecting an increase in endogenous glucose production together with decreased carbohydrate oxidation. Free fatty acids reflected the fasting-feeding pattern with increased free fatty acids before the meals and during the night when fat oxidation is highest and decreased free fatty acids after the meals. Plasma triglycerides displayed a rise throughout the waking hours with a peak after dinner, being the meal with the highest energy density. During the night, plasma triglycerides decreased again.

3.6. Circadian vs day-night rhythmicity {#sec3.6}
---------------------------------------

In this study, we aimed to examine changes in skeletal muscle mitochondrial function and whole-body metabolism throughout 24 h with a standardized protocol designed to mimic our daily lifestyle. To this end, our protocol included a normal sleep--wake cycle, normal meals with a regular calorie distribution and (limited) physical activity. As a result, our protocol does not allow us to evaluate the influence of the endogenous circadian clock *per se.* However, to control the influence of meals and physical activity, we performed our measurements under controlled conditions with meals and light activity bouts at least 3--4 h before the measurements. Such a protocol therefore reflects day-night, and not circadian rhythmicity, and allows extrapolation of the results to a normal daily lifestyle. The demonstration of a day-night rhythm in mitochondrial function in lean volunteers allows future studies to investigate if such rhythmicity is disturbed in volunteers with compromised metabolic health, such as T2DM. If rhythmicity of mitochondrial metabolism is indeed disturbed in subjects with compromised metabolic health, this may open therapeutic strategies to restore circadian rhythmicity, possibly via REV-ERB-α agonists or nutritional compounds as resveratrol, as they have previously been proven to be successful in mouse studies [@bib45], [@bib46]. Furthermore, it may open a new field of research directed towards the timing of interventions that boost mitochondrial function, and ultimately these studies may reveal how circadian disruption can lead to metabolic disturbances, as has been demonstrated in both human and animal studies [@bib6], [@bib7], [@bib42], [@bib43], [@bib44].

3.7. Conclusion {#sec3.7}
---------------

In conclusion, we here demonstrate the presence of a profound day-night rhythm in human skeletal muscle mitochondrial oxidative capacity. Peak oxidative capacity and highest resting energy expenditure coincide at the end of the day, thereby partly matching the time phase of peak physical performance as described in literature [@bib40], [@bib41]. In addition, we found significant variations over time in proteins involved in mitochondrial dynamics, possibly linking the circadian clock with mitochondrial metabolism. Future investigations should increase the focus on the regulatory mechanisms underlying the current observations. Moreover, it should be examined if disturbances of the rhythm in human skeletal muscle oxidative capacity play a pivotal role in the development of the adverse metabolic consequences of circadian misalignment.
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![**Study design**. Participants stayed in the research facility for 44 h starting at noon on day 1. During the second study-day we performed all measurements. B, breakfast; L, lunch; D, dinner; M, measurement (indirect calorimetry and muscle biopsy).](gr1){#fig1}

![**Time-dependent expression of transcripts in human skeletal muscle**. (A) Time-dependent gene expression was assessed by microarray analysis of RNA extracted from a single donor (N = 1). Protein-encoding transcript expression patterns were visualized as a self-organizing map (Euclidean distance metrics). The color scale indicates upregulated genes (red) and downregulated genes (green) relative to the global median signal of each array. The arrow indicates clusters of genes showing the most prominent peak of expression at the indicated time point (4 AM, cluster 1 and 11 PM, cluster 2). (B and C) Gene annotation enrichment analysis. The genes extracted from cluster 1 and 2 were searched using multiple databases (GeneOntology Biological Processes, KEGG pathways and Reactome) and statistically enriched terms were determined using the Metascape tool. The most significantly enriched terms are indicated for cluster 1 (GO biological processes, panel B, peak expression 4 AM) and cluster 2 (Reactome, panel C, peak expression 11 PM). Statistically significant terms were hierarchically clustered and converted into a network. Each term is represented by a circle node, of which the size is proportional to the number of genes in the term. The color of the node indicates the statistical significance of the term belonging to the cluster (see color scale). The most significant term characterizing each cluster is indicated. Similarities between terms are indicated by connecting lines.](gr2){#fig2}

![**Rhythmicity of core molecular clock genes in human skeletal muscle**. Diurnal mRNA expression of the arrhythmic muscle filament gene *TTN* (A), the core clock genes *CLOCK* and *BMAL1* (B), *PER2* and *CRY1* (C), measured by RT-QPCR. Data are normalized to the geometric mean of 3 housekeeping genes and presented as mean ± SEM. \*p \< 0.05 for the effect of time in all depicted genes.](gr3){#fig3}

![**Mitochondrial oxidative capacity in human skeletal muscle displays a day-night rhythm**. (A) ADP-stimulated respiration of permeabilized muscle fibers upon a lipid substrate (state 3 MO); fueled by complex I-linked substrates (state 3 MOG) and upon parallel electron input into complex I and II (state 3 MOGS). (B) Maximally uncoupled respiration upon FCCP (State U). M, malate; O, octanoylcarnitine; G, glutamate; S, succinate. Data represents oxygen consumption per mg wet weight per second and is depicted as mean ± SEM. \*p \< 0.05 for the effect of time in all states. \#p \< 0.05 vs 1 PM for Bonferroni-adjusted post-hoc analysis.](gr4){#fig4}

![**Mitochondrial content and mitochondrial marker proteins do not show rhythmicity**. (A) Measurement of mitochondrial DNA copy number (DNA copy numbers of the mitochondrial-encoded gene ND1 divided over the nuclear encoded gene LPL). (B) Representative western blot depicting the oxidative phosphorylation complexes of all time-points (C--G) Protein levels of specific subunits of complex I--V of the mitochondrial electron transport chain, measured by western blotting. (H--J) Protein levels of other mitochondrial (VDAC, TOMM-20) and non-mitochondrial (SR-Actin) proteins measured by western blotting. Representative western blot images are displayed below their respective graphs. Data expressed as mean ± SEM. p \> 0.05 for the effect of time in all panels.](gr5){#fig5}

![**Mitochondrial dynamics rather than mitochondrial biogenesis display a significant time-effect**. Protein levels of mitochondrial biogenesis regulator PGC-1α (A), mitochondrial fission protein FIS-1 (B), mitophagy protein PINK-1 (C) and mitochondrial fusion protein OPA-1 (D). Representative western blot images are displayed below their respective graphs. Data presented as mean ± SEM. \*p \< 0.05 for the effect of time.](gr6){#fig6}

![**Whole-body resting energy expenditure peaks at the same time as skeletal muscle oxidative capacity whereas substrate oxidation exhibits a clear feeding and fasting pattern**. Whole-body resting energy expenditure (A), respiratory exchange ratio (B), carbohydrate oxidation (C) and fat oxidation (D) during the second study-day, calculated from oxygen consumption and carbon-dioxide production measured by indirect calorimetry. Data presented as mean ± SEM. \*p \< 0.01 for the effect of time. \#p \< 0.05 for Bonferroni-adjusted post-hoc analysis.](gr7){#fig7}

![**Plasma metabolites and insulin display marked variations over 24 h, mostly associated with feeding-fasting**. Plasma levels of glucose (A), insulin (B), free fatty acids (C) and triglycerides (D) throughout the second-study day. Data depicted as mean ± SEM. \*p \< 0.001 for the effect of time.](gr8){#fig8}
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